New Alpha DaRT Research Collaboration on Immune Stimulation in the Treatment of Breast Cancer
JERUSALEM, Jan 20, 2022 – Alpha Tau Medical Ltd. (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha...
New Alpha DaRT Research Collaboration on Immune Stimulation in the Treatment of Breast Cancer
Results of First US Clinical Trial of Alpha DaRT™
Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head & Neck Cancer
Alpha DaRT Investigator Meeting in Las Vegas